Search

everythinglearnresearchcommunity

for

Search:↓

Proper nutrition can help manage PCOS symptoms and improve overall health.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

High levels of male hormones in women with PCOS can lead to fertility issues and symptoms like irregular periods, hair growth, acne, and hair loss; lifestyle changes are recommended for management.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair loss in women not always linked to increased oil production; other factors may be involved.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

Laser hair removal is effective for hirsutism when combined with treatment for the underlying causes.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Early hair loss may indicate future prostate issues.